JACK LIEBERMAN, M.D.; IRVING I. LASKY, M.D.; S. I. DULKIN, Ph.D.; OTTO E. LOBSTEIN, Ph.D.
The usefulness of the serum glutamic-oxalacetic transaminase (SGO-T) determination was cited in Part I of this report,1 and the limitations of this test in the evaluation of cardiac injury following accidents were demonstrated. This part will present an evaluation of the SGO-T test in cerebral vascular accidents and right heart failure, conditions that may be accompanied by myocardial infarction, and that involve tissues rich in glutamic-oxalacetic transaminase (GO-T) (brain and liver, respectively).
A cerebral vascular accident may be the presenting and sometimes the only symptom of a coronary occlusion. Bean and Read2, 3 described eight cases
LIEBERMAN J, LASKY II, DULKIN SI, et al. SERUM GLUTAMIC-OXALACETIC TRANSAMINASE ACTIVITY IN CONDITIONS ASSOCIATED WITH MYOCARDIAL INFARCTION. II. CEREBRAL VASCULAR ACCIDENTS AND CONGESTIVE HEART FAILURE1. Ann Intern Med. 1957;46:497–505. doi: 10.7326/0003-4819-46-3-497
Download citation file:
Published: Ann Intern Med. 1957;46(3):497-505.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine, Heart Failure.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use